# Ogi Kavazovic

> Ogi Kavazovic is the co-founder and CEO of House Rx, a San Francisco-based specialty pharmacy platform that enables clinical practices to dispense specialty medications directly to patients in-house. A serial operator who helped scale Opower (acquired by Oracle) and Flatiron Health (acquired by Roche), Ogi pivoted to fix a problem he kept seeing: patients leaving the doctor's office only to get lost in a broken specialty pharmacy system. House Rx has raised $100 million in total, including a $55 million Series B in November 2025, and now processes approximately $1.5 billion in specialty scripts annually across 80+ clinic sites.

- **Role:** Co-Founder and CEO at House Rx
- **Organizations:** House Rx, 1984 Ventures, Flatiron Health, Opower, Katzenbach Partners, Schlumberger Information Systems, Goldman Sachs, JP Morgan
- **Nationality:** American
- **Education:** Bachelor's in Computer Science, Harvard University, Master's in Computer Science, Harvard University
- **Known for:** Co-founded House Rx and scaled it to 280 employees and 80+ clinic sites in 4 years, Named Time Magazine's World's Top HealthTech Companies of 2025, Raised $100M+ in total funding for House Rx across multiple rounds

## Career timeline

- **2000s** — Software engineer building risk and asset management systems for Goldman Sachs and JP Morgan
- **2000s** — Lead architect of 'smart field' data management platform at Schlumberger Information Systems
- **Mid-2000s** — Management consultant at Katzenbach Partners advising Fortune 500 companies on corporate strategy and product investments
- **~2008-2015** — Joined Opower as an early employee; founded the company's marketing and strategy teams; rose to SVP of Product Management over 7 years
- **2015** — Joined Flatiron Health as Chief Marketing Officer and SVP of Product Strategy in December
- **2016** — Opower acquired by Oracle for approximately $532M
- **2018** — Flatiron Health acquired by Roche Pharmaceuticals
- **2021** — Co-founded House Rx to enable in-clinic specialty pharmacy dispensing
- **2022** — House Rx closes Series A led by Bessemer Venture Partners and 1984 Ventures
- **2023** — House Rx raises $30M Series A extension
- **2025** — House Rx raises $55M Series B led by NEA and Town Hall Ventures; named Time Magazine top HealthTech company

## Achievements

- Co-founded House Rx and scaled it to 280 employees and 80+ clinic sites in 4 years
- Named Time Magazine's World's Top HealthTech Companies of 2025
- Raised $100M+ in total funding for House Rx across multiple rounds
- Led product and marketing at Flatiron Health, acquired by Roche Pharmaceuticals (2018)
- Was early employee and SVP at Opower, acquired by Oracle for approximately $532M (2016)
- House Rx processes approximately $1.5 billion in specialty scripts per year, targeting $3B by end of 2026
- Built Smart PA AI feature that handles 80% of prior authorizations with 92% first-submission approval rate and 15-second generation time
- Achieved 95% medication adherence rate vs. industry standard of 70%
- Venture Partner at 1984 Ventures

## Latest updates

- **2025-11** — House Rx raises $55M Series B led by NEA and Town Hall Ventures, with participation from LRVHealth, First Round Capital, Bessemer Venture Partners, and Silicon Valley Bank
- **2025** — House Rx named one of Time Magazine's World's Top HealthTech Companies of 2025
- **2025** — House Rx projected to process $3B in specialty scripts by end of 2026, up from $1.5B current volume

## Links

- Website: https://houserx.com
- LinkedIn: https://www.linkedin.com/in/ogi-kavazovic-9ab68/
- Twitter/X: https://twitter.com/okavazovic
- YouTube: https://www.youtube.com/watch?v=RPPaPXK4QTM
- Instagram: https://www.instagram.com/ogo.kavazovic
- Facebook: https://www.facebook.com/ogi.kavazovic

---

Profile page: https://yespress.io/ogi-kavazovic
Published by YesPress — https://yespress.io
Last updated: 2026-05-24